[1/4] Excel → CSV 변환 중...
Saved pretrain CSV for TOX21_ERa_BLA_Antagonist_ratio: data/sample/TOX21_ERa_BLA_Antagonist_ratio.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Agonist: data/sample/TOX21_ERa_LUC_VM7_Agonist.csv
Saved pretrain CSV for TOX21_ERa_BLA_Antagonist_viability: data/sample/TOX21_ERa_BLA_Antagonist_viability.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2.csv
Saved pretrain CSV for TOX21_ERa_BLA_Antagonist_ch2: data/sample/TOX21_ERa_BLA_Antagonist_ch2.csv
Saved pretrain CSV for TOX21_ERa_BLA_Antagonist_ch1: data/sample/TOX21_ERa_BLA_Antagonist_ch1.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability.csv
Saved pretrain CSV for TOX21_ERa_BLA_Agonist_ch2: data/sample/TOX21_ERa_BLA_Agonist_ch2.csv
Saved pretrain CSV for TOX21_ERa_BLA_Agonist_ch1: data/sample/TOX21_ERa_BLA_Agonist_ch1.csv
Saved pretrain CSV for TOX21_ERa_BLA_Agonist_ratio: data/sample/TOX21_ERa_BLA_Agonist_ratio.csv
Saved pretrain CSV for TOX21_ERb_BLA_Antagonist_ch1: data/sample/TOX21_ERb_BLA_Antagonist_ch1.csv
Saved pretrain CSV for TOX21_ERb_BLA_Antagonist_ch2: data/sample/TOX21_ERb_BLA_Antagonist_ch2.csv
Saved pretrain CSV for TOX21_ERb_BLA_Agonist_viability: data/sample/TOX21_ERb_BLA_Agonist_viability.csv
Saved pretrain CSV for TOX21_ERb_BLA_Agonist_ratio: data/sample/TOX21_ERb_BLA_Agonist_ratio.csv
Saved pretrain CSV for TOX21_ERb_BLA_Agonist_ch2: data/sample/TOX21_ERb_BLA_Agonist_ch2.csv
Saved pretrain CSV for TOX21_ERb_BLA_Agonist_ch1: data/sample/TOX21_ERb_BLA_Agonist_ch1.csv
Saved pretrain CSV for TOX21_ERR_LUC_Agonist: data/sample/TOX21_ERR_LUC_Agonist.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability: data/sample/TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2.csv
Saved pretrain CSV for TOX21_ERb_BLA_Antagonist_ratio: data/sample/TOX21_ERb_BLA_Antagonist_ratio.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780: data/sample/TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780.csv
Saved pretrain CSV for TOX21_ERR_LUC_viability: data/sample/TOX21_ERR_LUC_viability.csv
Saved pretrain CSV for TOX21_ERR_LUC_Antagonist: data/sample/TOX21_ERR_LUC_Antagonist.csv
Saved pretrain CSV for TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability.csv
Saved pretrain CSV for TOX21_ERb_BLA_Antagonist_viability: data/sample/TOX21_ERb_BLA_Antagonist_viability.csv
Saved finetune CSV for TOX21_ERa_BLA_Antagonist_ratio: data/sample/TOX21_ERa_BLA_Antagonist_ratio.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Agonist: data/sample/TOX21_ERa_LUC_VM7_Agonist.csv
Saved finetune CSV for TOX21_ERa_BLA_Antagonist_viability: data/sample/TOX21_ERa_BLA_Antagonist_viability.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2.csv
Saved finetune CSV for TOX21_ERa_BLA_Antagonist_ch2: data/sample/TOX21_ERa_BLA_Antagonist_ch2.csv
Saved finetune CSV for TOX21_ERa_BLA_Antagonist_ch1: data/sample/TOX21_ERa_BLA_Antagonist_ch1.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability.csv
Saved finetune CSV for TOX21_ERa_BLA_Agonist_ch2: data/sample/TOX21_ERa_BLA_Agonist_ch2.csv
Saved finetune CSV for TOX21_ERa_BLA_Agonist_ch1: data/sample/TOX21_ERa_BLA_Agonist_ch1.csv
Saved finetune CSV for TOX21_ERa_BLA_Agonist_ratio: data/sample/TOX21_ERa_BLA_Agonist_ratio.csv
Saved finetune CSV for TOX21_ERb_BLA_Antagonist_ch1: data/sample/TOX21_ERb_BLA_Antagonist_ch1.csv
Saved finetune CSV for TOX21_ERb_BLA_Antagonist_ch2: data/sample/TOX21_ERb_BLA_Antagonist_ch2.csv
Saved finetune CSV for TOX21_ERb_BLA_Agonist_viability: data/sample/TOX21_ERb_BLA_Agonist_viability.csv
Saved finetune CSV for TOX21_ERb_BLA_Agonist_ratio: data/sample/TOX21_ERb_BLA_Agonist_ratio.csv
Saved finetune CSV for TOX21_ERb_BLA_Agonist_ch2: data/sample/TOX21_ERb_BLA_Agonist_ch2.csv
Saved finetune CSV for TOX21_ERb_BLA_Agonist_ch1: data/sample/TOX21_ERb_BLA_Agonist_ch1.csv
Saved finetune CSV for TOX21_ERR_LUC_Agonist: data/sample/TOX21_ERR_LUC_Agonist.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability: data/sample/TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2.csv
Saved finetune CSV for TOX21_ERb_BLA_Antagonist_ratio: data/sample/TOX21_ERb_BLA_Antagonist_ratio.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780: data/sample/TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780.csv
Saved finetune CSV for TOX21_ERR_LUC_viability: data/sample/TOX21_ERR_LUC_viability.csv
Saved finetune CSV for TOX21_ERR_LUC_Antagonist: data/sample/TOX21_ERR_LUC_Antagonist.csv
Saved finetune CSV for TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability: data/sample/TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability.csv
Saved finetune CSV for TOX21_ERb_BLA_Antagonist_viability: data/sample/TOX21_ERb_BLA_Antagonist_viability.csv
[2/4] Pretraining on TOX21_ERa_BLA_Antagonist_ratio using GIN_GCN...
Epoch 1/50 - Loss: 0.6225 - Val F1: 0.3190 - Val ROC-AUC: 0.7308 - Val PR-AUC: 0.3158
Epoch 2/50 - Loss: 0.5833 - Val F1: 0.3497 - Val ROC-AUC: 0.7471 - Val PR-AUC: 0.2973
Epoch 3/50 - Loss: 0.5753 - Val F1: 0.3427 - Val ROC-AUC: 0.7749 - Val PR-AUC: 0.3403
Epoch 4/50 - Loss: 0.5586 - Val F1: 0.3765 - Val ROC-AUC: 0.7753 - Val PR-AUC: 0.3360
Epoch 5/50 - Loss: 0.5386 - Val F1: 0.3451 - Val ROC-AUC: 0.7792 - Val PR-AUC: 0.3443
Epoch 6/50 - Loss: 0.5338 - Val F1: 0.3745 - Val ROC-AUC: 0.7863 - Val PR-AUC: 0.3633
Epoch 7/50 - Loss: 0.5127 - Val F1: 0.4181 - Val ROC-AUC: 0.8020 - Val PR-AUC: 0.3834
Epoch 8/50 - Loss: 0.5109 - Val F1: 0.3867 - Val ROC-AUC: 0.7736 - Val PR-AUC: 0.3449
Epoch 9/50 - Loss: 0.5250 - Val F1: 0.4056 - Val ROC-AUC: 0.7896 - Val PR-AUC: 0.3296
Epoch 10/50 - Loss: 0.4970 - Val F1: 0.3796 - Val ROC-AUC: 0.7917 - Val PR-AUC: 0.3596
Epoch 11/50 - Loss: 0.4764 - Val F1: 0.4229 - Val ROC-AUC: 0.8164 - Val PR-AUC: 0.4169
Epoch 12/50 - Loss: 0.4570 - Val F1: 0.4432 - Val ROC-AUC: 0.8196 - Val PR-AUC: 0.4113
Epoch 13/50 - Loss: 0.4583 - Val F1: 0.4413 - Val ROC-AUC: 0.8078 - Val PR-AUC: 0.3884
Epoch 14/50 - Loss: 0.4517 - Val F1: 0.4390 - Val ROC-AUC: 0.8279 - Val PR-AUC: 0.4502
Epoch 15/50 - Loss: 0.4502 - Val F1: 0.4010 - Val ROC-AUC: 0.7916 - Val PR-AUC: 0.3556
Epoch 16/50 - Loss: 0.4429 - Val F1: 0.4489 - Val ROC-AUC: 0.8223 - Val PR-AUC: 0.4220
Epoch 17/50 - Loss: 0.4369 - Val F1: 0.4828 - Val ROC-AUC: 0.8262 - Val PR-AUC: 0.4325
Epoch 18/50 - Loss: 0.4346 - Val F1: 0.4368 - Val ROC-AUC: 0.8241 - Val PR-AUC: 0.4563
Epoch 19/50 - Loss: 0.4309 - Val F1: 0.4257 - Val ROC-AUC: 0.8165 - Val PR-AUC: 0.4151
Epoch 20/50 - Loss: 0.4233 - Val F1: 0.4208 - Val ROC-AUC: 0.8184 - Val PR-AUC: 0.4124
Epoch 21/50 - Loss: 0.4084 - Val F1: 0.4591 - Val ROC-AUC: 0.8282 - Val PR-AUC: 0.4399
Epoch 22/50 - Loss: 0.4015 - Val F1: 0.4562 - Val ROC-AUC: 0.8230 - Val PR-AUC: 0.4342
Epoch 23/50 - Loss: 0.3917 - Val F1: 0.4257 - Val ROC-AUC: 0.8137 - Val PR-AUC: 0.4195
Epoch 24/50 - Loss: 0.3938 - Val F1: 0.4444 - Val ROC-AUC: 0.8198 - Val PR-AUC: 0.4327
Epoch 25/50 - Loss: 0.3875 - Val F1: 0.4305 - Val ROC-AUC: 0.8315 - Val PR-AUC: 0.4521
Epoch 26/50 - Loss: 0.3783 - Val F1: 0.4171 - Val ROC-AUC: 0.8292 - Val PR-AUC: 0.4586
Epoch 27/50 - Loss: 0.3744 - Val F1: 0.4523 - Val ROC-AUC: 0.8233 - Val PR-AUC: 0.4248
Epoch 28/50 - Loss: 0.3712 - Val F1: 0.4845 - Val ROC-AUC: 0.8428 - Val PR-AUC: 0.4599
Epoch 29/50 - Loss: 0.3551 - Val F1: 0.4653 - Val ROC-AUC: 0.8272 - Val PR-AUC: 0.4297
Epoch 30/50 - Loss: 0.3623 - Val F1: 0.4615 - Val ROC-AUC: 0.8387 - Val PR-AUC: 0.4579
Epoch 31/50 - Loss: 0.3520 - Val F1: 0.4596 - Val ROC-AUC: 0.8316 - Val PR-AUC: 0.4512
Epoch 32/50 - Loss: 0.3448 - Val F1: 0.4684 - Val ROC-AUC: 0.8355 - Val PR-AUC: 0.4655
Epoch 33/50 - Loss: 0.3487 - Val F1: 0.4459 - Val ROC-AUC: 0.8270 - Val PR-AUC: 0.4502
Epoch 34/50 - Loss: 0.3412 - Val F1: 0.4867 - Val ROC-AUC: 0.8341 - Val PR-AUC: 0.4569
Epoch 35/50 - Loss: 0.3328 - Val F1: 0.4686 - Val ROC-AUC: 0.8282 - Val PR-AUC: 0.4229
Epoch 36/50 - Loss: 0.3328 - Val F1: 0.4620 - Val ROC-AUC: 0.8360 - Val PR-AUC: 0.4512
Epoch 37/50 - Loss: 0.3365 - Val F1: 0.4848 - Val ROC-AUC: 0.8374 - Val PR-AUC: 0.4434
Epoch 38/50 - Loss: 0.3222 - Val F1: 0.4916 - Val ROC-AUC: 0.8328 - Val PR-AUC: 0.4289
Epoch 39/50 - Loss: 0.3344 - Val F1: 0.4865 - Val ROC-AUC: 0.8369 - Val PR-AUC: 0.4510
Epoch 40/50 - Loss: 0.3315 - Val F1: 0.4539 - Val ROC-AUC: 0.8256 - Val PR-AUC: 0.4232
Epoch 41/50 - Loss: 0.3181 - Val F1: 0.4639 - Val ROC-AUC: 0.8348 - Val PR-AUC: 0.4403
Epoch 42/50 - Loss: 0.3188 - Val F1: 0.4582 - Val ROC-AUC: 0.8318 - Val PR-AUC: 0.4490
Epoch 43/50 - Loss: 0.3071 - Val F1: 0.4545 - Val ROC-AUC: 0.8247 - Val PR-AUC: 0.4291
Epoch 44/50 - Loss: 0.3113 - Val F1: 0.4641 - Val ROC-AUC: 0.8319 - Val PR-AUC: 0.4394
Epoch 45/50 - Loss: 0.3028 - Val F1: 0.4747 - Val ROC-AUC: 0.8377 - Val PR-AUC: 0.4539
Epoch 46/50 - Loss: 0.2934 - Val F1: 0.4815 - Val ROC-AUC: 0.8395 - Val PR-AUC: 0.4421
Epoch 47/50 - Loss: 0.3075 - Val F1: 0.4728 - Val ROC-AUC: 0.8363 - Val PR-AUC: 0.4422
Epoch 48/50 - Loss: 0.3040 - Val F1: 0.4749 - Val ROC-AUC: 0.8383 - Val PR-AUC: 0.4529
Epoch 49/50 - Loss: 0.2946 - Val F1: 0.4605 - Val ROC-AUC: 0.8240 - Val PR-AUC: 0.4377
Epoch 50/50 - Loss: 0.2894 - Val F1: 0.4784 - Val ROC-AUC: 0.8287 - Val PR-AUC: 0.4352
Pretraining completed. Test F1: 0.4385, ROC-AUC: 0.8059, PR-AUC: 0.3347
[3/4] Finetuning on TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability using GIN_GCN...
[Fine-tune] Epoch 1/50 - Loss: 0.4649 - Val F1: 0.3394 - Val ROC-AUC: 0.8532 - Val PR-AUC: 0.3725
[Fine-tune] Epoch 2/50 - Loss: 0.4062 - Val F1: 0.3846 - Val ROC-AUC: 0.8538 - Val PR-AUC: 0.3627
[Fine-tune] Epoch 3/50 - Loss: 0.3800 - Val F1: 0.3382 - Val ROC-AUC: 0.8491 - Val PR-AUC: 0.3105
[Fine-tune] Epoch 4/50 - Loss: 0.3667 - Val F1: 0.3407 - Val ROC-AUC: 0.8685 - Val PR-AUC: 0.3225
[Fine-tune] Epoch 5/50 - Loss: 0.3398 - Val F1: 0.3877 - Val ROC-AUC: 0.8733 - Val PR-AUC: 0.3674
[Fine-tune] Epoch 6/50 - Loss: 0.3368 - Val F1: 0.3882 - Val ROC-AUC: 0.8521 - Val PR-AUC: 0.3253
[Fine-tune] Epoch 7/50 - Loss: 0.3315 - Val F1: 0.3358 - Val ROC-AUC: 0.8477 - Val PR-AUC: 0.3383
[Fine-tune] Epoch 8/50 - Loss: 0.3257 - Val F1: 0.3351 - Val ROC-AUC: 0.8384 - Val PR-AUC: 0.3430
[Fine-tune] Epoch 9/50 - Loss: 0.3241 - Val F1: 0.3982 - Val ROC-AUC: 0.8617 - Val PR-AUC: 0.3672
[Fine-tune] Epoch 10/50 - Loss: 0.3077 - Val F1: 0.3565 - Val ROC-AUC: 0.8385 - Val PR-AUC: 0.3312
[Fine-tune] Epoch 11/50 - Loss: 0.2617 - Val F1: 0.3814 - Val ROC-AUC: 0.8743 - Val PR-AUC: 0.4090
[Fine-tune] Epoch 12/50 - Loss: 0.2466 - Val F1: 0.3944 - Val ROC-AUC: 0.8637 - Val PR-AUC: 0.3813
[Fine-tune] Epoch 13/50 - Loss: 0.2498 - Val F1: 0.3587 - Val ROC-AUC: 0.8399 - Val PR-AUC: 0.3583
[Fine-tune] Epoch 14/50 - Loss: 0.2391 - Val F1: 0.4070 - Val ROC-AUC: 0.8480 - Val PR-AUC: 0.3524
[Fine-tune] Epoch 15/50 - Loss: 0.2405 - Val F1: 0.3842 - Val ROC-AUC: 0.8685 - Val PR-AUC: 0.3768
[Fine-tune] Epoch 16/50 - Loss: 0.2103 - Val F1: 0.3378 - Val ROC-AUC: 0.8396 - Val PR-AUC: 0.3375
[Fine-tune] Epoch 17/50 - Loss: 0.2116 - Val F1: 0.4055 - Val ROC-AUC: 0.8616 - Val PR-AUC: 0.3804
[Fine-tune] Epoch 18/50 - Loss: 0.2084 - Val F1: 0.4082 - Val ROC-AUC: 0.8494 - Val PR-AUC: 0.3763
[Fine-tune] Epoch 19/50 - Loss: 0.2163 - Val F1: 0.3874 - Val ROC-AUC: 0.8401 - Val PR-AUC: 0.3602
[Fine-tune] Epoch 20/50 - Loss: 0.2071 - Val F1: 0.3854 - Val ROC-AUC: 0.8443 - Val PR-AUC: 0.3660
[Fine-tune] Epoch 21/50 - Loss: 0.1885 - Val F1: 0.4379 - Val ROC-AUC: 0.8440 - Val PR-AUC: 0.3804
[Fine-tune] Epoch 22/50 - Loss: 0.1621 - Val F1: 0.4094 - Val ROC-AUC: 0.8416 - Val PR-AUC: 0.3480
[Fine-tune] Epoch 23/50 - Loss: 0.1566 - Val F1: 0.3858 - Val ROC-AUC: 0.8426 - Val PR-AUC: 0.3561
[Fine-tune] Epoch 24/50 - Loss: 0.1581 - Val F1: 0.4260 - Val ROC-AUC: 0.8346 - Val PR-AUC: 0.3653
[Fine-tune] Epoch 25/50 - Loss: 0.1699 - Val F1: 0.3957 - Val ROC-AUC: 0.8385 - Val PR-AUC: 0.3657
[Fine-tune] Epoch 26/50 - Loss: 0.1633 - Val F1: 0.4000 - Val ROC-AUC: 0.8234 - Val PR-AUC: 0.3714
[Fine-tune] Epoch 27/50 - Loss: 0.1642 - Val F1: 0.3913 - Val ROC-AUC: 0.8355 - Val PR-AUC: 0.3592
[Fine-tune] Epoch 28/50 - Loss: 0.1507 - Val F1: 0.4171 - Val ROC-AUC: 0.8436 - Val PR-AUC: 0.4013
[Fine-tune] Epoch 29/50 - Loss: 0.1430 - Val F1: 0.4066 - Val ROC-AUC: 0.8386 - Val PR-AUC: 0.3733
[Fine-tune] Epoch 30/50 - Loss: 0.1393 - Val F1: 0.3953 - Val ROC-AUC: 0.8310 - Val PR-AUC: 0.3601
[Fine-tune] Epoch 31/50 - Loss: 0.1404 - Val F1: 0.4268 - Val ROC-AUC: 0.8338 - Val PR-AUC: 0.3636
[Fine-tune] Epoch 32/50 - Loss: 0.1261 - Val F1: 0.4311 - Val ROC-AUC: 0.8377 - Val PR-AUC: 0.3713
[Fine-tune] Epoch 33/50 - Loss: 0.1265 - Val F1: 0.3953 - Val ROC-AUC: 0.8302 - Val PR-AUC: 0.3746
[Fine-tune] Epoch 34/50 - Loss: 0.1181 - Val F1: 0.4024 - Val ROC-AUC: 0.8252 - Val PR-AUC: 0.3464
[Fine-tune] Epoch 35/50 - Loss: 0.1255 - Val F1: 0.4359 - Val ROC-AUC: 0.8295 - Val PR-AUC: 0.3750
[Fine-tune] Epoch 36/50 - Loss: 0.1245 - Val F1: 0.3958 - Val ROC-AUC: 0.8315 - Val PR-AUC: 0.3611
[Fine-tune] Epoch 37/50 - Loss: 0.1228 - Val F1: 0.4000 - Val ROC-AUC: 0.8360 - Val PR-AUC: 0.3499
[Fine-tune] Epoch 38/50 - Loss: 0.1153 - Val F1: 0.4186 - Val ROC-AUC: 0.8328 - Val PR-AUC: 0.3733
[Fine-tune] Epoch 39/50 - Loss: 0.1100 - Val F1: 0.4027 - Val ROC-AUC: 0.8270 - Val PR-AUC: 0.3562
[Fine-tune] Epoch 40/50 - Loss: 0.1223 - Val F1: 0.4528 - Val ROC-AUC: 0.8301 - Val PR-AUC: 0.3679
[Fine-tune] Epoch 41/50 - Loss: 0.1254 - Val F1: 0.4294 - Val ROC-AUC: 0.8286 - Val PR-AUC: 0.3804
[Fine-tune] Epoch 42/50 - Loss: 0.1155 - Val F1: 0.3879 - Val ROC-AUC: 0.8252 - Val PR-AUC: 0.3757
[Fine-tune] Epoch 43/50 - Loss: 0.1068 - Val F1: 0.4387 - Val ROC-AUC: 0.8296 - Val PR-AUC: 0.3752
[Fine-tune] Epoch 44/50 - Loss: 0.1074 - Val F1: 0.4099 - Val ROC-AUC: 0.8318 - Val PR-AUC: 0.3889
[Fine-tune] Epoch 45/50 - Loss: 0.1153 - Val F1: 0.4242 - Val ROC-AUC: 0.8330 - Val PR-AUC: 0.3889
[Fine-tune] Epoch 46/50 - Loss: 0.1007 - Val F1: 0.4198 - Val ROC-AUC: 0.8290 - Val PR-AUC: 0.3731
[Fine-tune] Epoch 47/50 - Loss: 0.1019 - Val F1: 0.4247 - Val ROC-AUC: 0.8274 - Val PR-AUC: 0.3663
[Fine-tune] Epoch 48/50 - Loss: 0.0981 - Val F1: 0.4405 - Val ROC-AUC: 0.8300 - Val PR-AUC: 0.3857
[Fine-tune] Epoch 49/50 - Loss: 0.1131 - Val F1: 0.4198 - Val ROC-AUC: 0.8290 - Val PR-AUC: 0.3661
[Fine-tune] Epoch 50/50 - Loss: 0.0900 - Val F1: 0.4099 - Val ROC-AUC: 0.8285 - Val PR-AUC: 0.3798
Finetuning completed. Test F1: 0.4568, ROC-AUC: 0.8764, PR-AUC: 0.3479
[3.1/4] Target-only training on TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability using GIN_GCN...
=== Target-only training ===
[Target-only] Epoch 1/50 – Loss: 0.5956  Val F1: 0.3100  ROC-AUC: 0.8147  PR-AUC: 0.2107
[Target-only] Epoch 2/50 – Loss: 0.5240  Val F1: 0.2627  ROC-AUC: 0.7885  PR-AUC: 0.1850
[Target-only] Epoch 3/50 – Loss: 0.4781  Val F1: 0.3167  ROC-AUC: 0.8281  PR-AUC: 0.2684
[Target-only] Epoch 4/50 – Loss: 0.4732  Val F1: 0.3274  ROC-AUC: 0.8205  PR-AUC: 0.2830
[Target-only] Epoch 5/50 – Loss: 0.4531  Val F1: 0.2216  ROC-AUC: 0.7777  PR-AUC: 0.2714
[Target-only] Epoch 6/50 – Loss: 0.4267  Val F1: 0.3150  ROC-AUC: 0.8228  PR-AUC: 0.3226
[Target-only] Epoch 7/50 – Loss: 0.4269  Val F1: 0.3213  ROC-AUC: 0.8356  PR-AUC: 0.3175
[Target-only] Epoch 8/50 – Loss: 0.4015  Val F1: 0.3048  ROC-AUC: 0.8435  PR-AUC: 0.3620
[Target-only] Epoch 9/50 – Loss: 0.3977  Val F1: 0.2947  ROC-AUC: 0.8373  PR-AUC: 0.3477
[Target-only] Epoch 10/50 – Loss: 0.3870  Val F1: 0.3077  ROC-AUC: 0.8650  PR-AUC: 0.3449
[Target-only] Epoch 11/50 – Loss: 0.3575  Val F1: 0.3662  ROC-AUC: 0.8503  PR-AUC: 0.3363
[Target-only] Epoch 12/50 – Loss: 0.3352  Val F1: 0.4199  ROC-AUC: 0.8595  PR-AUC: 0.3600
[Target-only] Epoch 13/50 – Loss: 0.3326  Val F1: 0.3455  ROC-AUC: 0.8388  PR-AUC: 0.3495
[Target-only] Epoch 14/50 – Loss: 0.3180  Val F1: 0.3669  ROC-AUC: 0.8461  PR-AUC: 0.3483
[Target-only] Epoch 15/50 – Loss: 0.3192  Val F1: 0.3761  ROC-AUC: 0.8517  PR-AUC: 0.3642
[Target-only] Epoch 16/50 – Loss: 0.3211  Val F1: 0.4162  ROC-AUC: 0.8390  PR-AUC: 0.3888
[Target-only] Epoch 17/50 – Loss: 0.3076  Val F1: 0.3743  ROC-AUC: 0.8313  PR-AUC: 0.3396
[Target-only] Epoch 18/50 – Loss: 0.2945  Val F1: 0.3594  ROC-AUC: 0.8445  PR-AUC: 0.3915
[Target-only] Epoch 19/50 – Loss: 0.3009  Val F1: 0.3636  ROC-AUC: 0.8431  PR-AUC: 0.3627
[Target-only] Epoch 20/50 – Loss: 0.2739  Val F1: 0.3618  ROC-AUC: 0.8616  PR-AUC: 0.3587
[Target-only] Epoch 21/50 – Loss: 0.2637  Val F1: 0.3804  ROC-AUC: 0.8503  PR-AUC: 0.3566
[Target-only] Epoch 22/50 – Loss: 0.2413  Val F1: 0.3491  ROC-AUC: 0.8489  PR-AUC: 0.3375
[Target-only] Epoch 23/50 – Loss: 0.2578  Val F1: 0.3800  ROC-AUC: 0.8563  PR-AUC: 0.3583
[Target-only] Epoch 24/50 – Loss: 0.2373  Val F1: 0.3979  ROC-AUC: 0.8486  PR-AUC: 0.3409
[Target-only] Epoch 25/50 – Loss: 0.2429  Val F1: 0.3842  ROC-AUC: 0.8431  PR-AUC: 0.3594
[Target-only] Epoch 26/50 – Loss: 0.2334  Val F1: 0.3977  ROC-AUC: 0.8552  PR-AUC: 0.3459
[Target-only] Epoch 27/50 – Loss: 0.2356  Val F1: 0.3874  ROC-AUC: 0.8378  PR-AUC: 0.3622
[Target-only] Epoch 28/50 – Loss: 0.2279  Val F1: 0.3656  ROC-AUC: 0.8497  PR-AUC: 0.3428
[Target-only] Epoch 29/50 – Loss: 0.2279  Val F1: 0.4000  ROC-AUC: 0.8601  PR-AUC: 0.3593
[Target-only] Epoch 30/50 – Loss: 0.2188  Val F1: 0.3365  ROC-AUC: 0.8344  PR-AUC: 0.3364
[Target-only] Epoch 31/50 – Loss: 0.2168  Val F1: 0.3789  ROC-AUC: 0.8493  PR-AUC: 0.3779
[Target-only] Epoch 32/50 – Loss: 0.2004  Val F1: 0.3737  ROC-AUC: 0.8493  PR-AUC: 0.3730
[Target-only] Epoch 33/50 – Loss: 0.1986  Val F1: 0.3897  ROC-AUC: 0.8435  PR-AUC: 0.3682
[Target-only] Epoch 34/50 – Loss: 0.1956  Val F1: 0.3784  ROC-AUC: 0.8477  PR-AUC: 0.3681
[Target-only] Epoch 35/50 – Loss: 0.2048  Val F1: 0.4091  ROC-AUC: 0.8543  PR-AUC: 0.3985
[Target-only] Epoch 36/50 – Loss: 0.1845  Val F1: 0.4162  ROC-AUC: 0.8519  PR-AUC: 0.4013
[Target-only] Epoch 37/50 – Loss: 0.1860  Val F1: 0.4108  ROC-AUC: 0.8538  PR-AUC: 0.3866
[Target-only] Epoch 38/50 – Loss: 0.1940  Val F1: 0.3864  ROC-AUC: 0.8476  PR-AUC: 0.3755
[Target-only] Epoch 39/50 – Loss: 0.1825  Val F1: 0.4286  ROC-AUC: 0.8450  PR-AUC: 0.3830
[Target-only] Epoch 40/50 – Loss: 0.1769  Val F1: 0.4277  ROC-AUC: 0.8513  PR-AUC: 0.3576
[Target-only] Epoch 41/50 – Loss: 0.1689  Val F1: 0.4118  ROC-AUC: 0.8438  PR-AUC: 0.3707
[Target-only] Epoch 42/50 – Loss: 0.1750  Val F1: 0.4246  ROC-AUC: 0.8430  PR-AUC: 0.3860
[Target-only] Epoch 43/50 – Loss: 0.1722  Val F1: 0.4286  ROC-AUC: 0.8444  PR-AUC: 0.3690
[Target-only] Epoch 44/50 – Loss: 0.1574  Val F1: 0.4127  ROC-AUC: 0.8475  PR-AUC: 0.3680
[Target-only] Epoch 45/50 – Loss: 0.1684  Val F1: 0.3933  ROC-AUC: 0.8386  PR-AUC: 0.3756
[Target-only] Epoch 46/50 – Loss: 0.1751  Val F1: 0.3780  ROC-AUC: 0.8422  PR-AUC: 0.3693
[Target-only] Epoch 47/50 – Loss: 0.1527  Val F1: 0.3957  ROC-AUC: 0.8481  PR-AUC: 0.3648
[Target-only] Epoch 48/50 – Loss: 0.1599  Val F1: 0.4000  ROC-AUC: 0.8456  PR-AUC: 0.3862
[Target-only] Epoch 49/50 – Loss: 0.1575  Val F1: 0.4064  ROC-AUC: 0.8504  PR-AUC: 0.4003
[Target-only] Epoch 50/50 – Loss: 0.1603  Val F1: 0.3978  ROC-AUC: 0.8428  PR-AUC: 0.3691
=== Target-only TEST performance ===
Test F1: 0.3804, ROC-AUC: 0.8586, PR-AUC: 0.3533
✅ 실험 완료: TOX21_ERa_BLA_Antagonist_ratio -> TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability [GIN_GCN]
